Lindsay Alpert to Cetuximab
This is a "connection" page, showing publications Lindsay Alpert has written about Cetuximab.
Connection Strength
0.147
-
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov. 2018 06; 8(6):696-713.
Score: 0.147